Please replace the release issued July 30, 2018 with the following
corrected version due to multiple revisions.
This press release features multimedia. View the full release here:
SCIEX Topaz Prep Station (Photo: Business Wire)
The corrected release reads:
SCIEX PRESENTS CLINICAL SOLUTIONS FOR ROUTINE DIAGNOSTICS AND
INNOVATIVE RESEARCH AT AACC
New Topaz™ Prep Station and Vitamin D 200A Assay Kit streamline
workflows to simplify sample prep, improving ROI
a global leader in life science analytical technologies, advanced the
accessibility of mass spectrometry in the clinical setting with new
product introductions at AACC 2018. These products add to the company’s
existing industry leading solutions and services, to deliver the power
of mass spectrometry to clinical laboratories performing routine
diagnostic assays and innovative clinical research applications.
Today, SCIEX announced the launch of the new Topaz™ Prep Station*,
an automated sample preparation workstation that is ideal for labs
managing high daily sample volumes. The Topaz Prep Station supports the Topaz™
LC-MS/MS System, a Class I Medical Device designed to simplify
adoption for new mass spectrometry users, while still offering the
functionality needed for more advanced users.
Along with the Topaz Prep Station, SCIEX also announced the introduction
of the new automated Vitamin D 200A Assay Kit*. This kit is a
locked, pre-validated assay that allows labs to perform vitamin D
analysis in-house, and employs automated sample preparation on the Topaz
Prep Station to deliver highly accurate results to support medical
decisions and quality patient care.
Together, the Topaz Prep Station and the Vitamin D 200A Assay Kit
enables clinical diagnostic testing labs to:
The Topaz System makes the move to mass spectrometry simple and
efficient by providing clinical diagnostics laboratories a complete
LC-MS/MS package, with an easy-to-use, intuitive user interface that
allows users to build proficiency quickly.
“We are excited to offer our latest developments, designed to bring the
reliability and accuracy of LC-MS/MS to clinical labs,” said Aaron
Hudson, Vice President of Global Marketing and Clinical Diagnostics at
SCIEX. “While supporting our rapidly growing portfolio of innovative
solutions, SCIEX aspires to provide cutting edge technology while
reducing the complexity for the user.”
Earlier this year, SCIEX launched the Citrine™ MS/MS system, the
front-line alternative for clinical diagnostics. With its unique
combination of sensitivity and speed, the Citrine system enables trace
level analysis, comprehensive panels and the measurement of both large
and small molecules.
At AACC, SCIEX will showcase the Topaz LC-MS/MS System, the Topaz Prep
Station and the Citrine MS/MS medical devices at booth #3909. In
addition to its medical devices portfolio, SCIEX will feature clinical
research innovations and workflows that support efforts in biomarker
discovery and validation, recognizing that new biomarkers today could be
applied as routine diagnostic assays of the future. The partnership
between SCIEX and Phenomenex,
a global leader in separation science techniques, also leads to a wide
range of workflow and data quality-enhancing solutions, which will be
displayed at the booth.
Throughout the week, experts from SCIEX will provide a series of
in-booth seminars and a round table discussion on how mass spectrometry
technology can be seamlessly adopted in any clinical lab. For more
information, please visit https://sciex.com/events/aacc-2018.
*Product not currently available for sale, pending registration and
listing in the U.S. Product will only be available in the U.S.
SCIEX helps to improve the world we live in by enabling scientists and
laboratory analysts to find answers to the complex analytical challenges
they face. The company’s global leadership and world-class service and
support in the capillary electrophoresis and liquid chromatography-mass
spectrometry industry have made it a trusted partner to thousands of the
scientists and lab analysts worldwide who are focused on basic research,
drug discovery and development, food and environmental testing,
forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to
and understanding the ever-evolving needs of its customers to develop
reliable, sensitive and intuitive solutions that continue to redefine
what is achievable in routine and complex analysis. For more
information, please visit sciex.com/diagnostics.
SCIEX social: Twitter: @SCIEXnews,
AB Sciex is operating as SCIEX.
©2018 AB Sciex. The trademarks mentioned herein are the property of the
AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used
For in vitro diagnostic use. Rx Only. Product(s) not available in
all countries. For information on availability, please contact your
View source version on businesswire.com: https://www.businesswire.com/news/home/20180730005163/en/